Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4NATURE COMMUNICATIONSIF15.72023-04-2515OAAI
Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatmentSCIENTIFIC REPORTSIF3.92020-03-035OAAI
In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat modelMABSIF7.32019-11-2616OAAI
AllergoOncology: Expression platform development and functional profiling of an anti-HER2 IgE antibodyALLERGYIF122019-05-2712OAAI
Combined Inhibition of TGF- Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor ModelsCELLSIF5.22019-04-0592OAAI
High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody TherapyJOURNAL OF IMMUNOLOGYIF3.42018-12-157OA
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor modelINTERNATIONAL JOURNAL OF CANCERIF4.72018-11-1213OAAI
A Restricted Role for FcγR in the Regulation of Adaptive ImmunityJOURNAL OF IMMUNOLOGYIF3.42018-04-1514OAAI
Combining low-dose or metronomic chemotherapy with anticancer vaccines A therapeutic opportunity for lymphomasONCOIMMUNOLOGYIF6.32014-10-2729OAAI